FindTrial
Sign In

a serum marker as a predictor to outcome in severly ill injured patients

Serum Transthyretin as predictor to outcome in critically ill trauma patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/05/018883
Enrollment
200
Registered
2019-05-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T07- Unspecified multiple injuries

Interventions

None listed

Sponsors

institute of medical sciences BHU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Critically ill Trauma patients

Exclusion criteria

Exclusion criteria: 1.Not consenting 2. pregnancy 3. Hemodynamically unstable patients 4. Associated liver diseases 5. Heart diseases 6. Renal diseases

Design outcomes

Primary

MeasureTime frame
Serum transthyretin level as a biomarker for outcome in intensive care unit Timepoint: 1,3, 5, 7 ,28 DAYS—

Secondary

MeasureTime frame
Days of ventilator stay, length of ICU stay, length of hospital stay and mortalityTimepoint: 28 DAYS—

Countries

India

Contacts

Public ContactManjaree Mishra

Institute of Medical Sciences, BHU

drmanjareemd@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026